The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026).
 
Britt Kristina Erickson
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Merck
 
Danielle Enserro
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Lauren E. Dockery
No Relationships to Disclose
 
sharad A. ghamande
Consulting or Advisory Role - Seagen
Speakers' Bureau - Eisai; Tesaro/GSK
Research Funding - Abbvie (Inst); Advaxis (Inst); Akeso Biopharma (Inst); Aravive (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Ellipses Pharma (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Merck (Inst); Merck Serono (Inst); Roche (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst)
 
Matthew T. Oliver
No Relationships to Disclose
 
Gregory M. Gressel
No Relationships to Disclose
 
Tara Castellano
No Relationships to Disclose
 
Elena Ratner
Consulting or Advisory Role - Zai Lab
Expert Testimony - Expert Consulting Services
 
Amy Deery
No Relationships to Disclose
 
Erin Bishop
No Relationships to Disclose
 
Leslie Siriya Bradford
No Relationships to Disclose
 
Jessica Thomes Pepin
No Relationships to Disclose
 
Elizabeth Burton
No Relationships to Disclose
 
Stephanie V. Blank
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Aravive (Inst); AstraZeneca (Inst); F. Hoffmann LaRoche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Alessandro Santin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai; Merck; R-Pharm; Tesaro
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Merck (Inst); Puma Biotechnology (Inst); R-Pharm (Inst); Tesaro (Inst); Verastem (Inst)
 
Laura J Havrilesky
Employment - BIOVENTUS (I)
Research Funding - AstraZeneca; Tesaro
 
Carol Aghajanian
Leadership - GOG Foundation
Consulting or Advisory Role - AstraZeneca; Merck
Research Funding - Abbvie (Inst); Artios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Amanda Nickles Fader
Honoraria - GlaxoSmithKline; Onconova Therapeutics; Verastem
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Immunogen; Merck; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)